The present invention relates to a pharmaceutical preparation for treating aninflammatory condition, preferably acondition associated with ischemia comprising: a) a physiological solutioncomprising peripheral blood mononuclear cells(PBM--Cs) or a subset thereof, or b) a supernatant of the solution a), whereinthe solution a) is obtainable by cultivating PBMCs or asubset thereof in a physiological solution free of PBMC-proliferating and PBMC-activating substances for at least 1 h.